Benfotiamine And Diabetic Retinopathy -

Home
>
Diabetes
>
Benfotiamine And Diabetic Retinopathy

Benfotiamine And Diabetic Retinopathy

Damage from diabetes can occur in different areas of the eye. It can occur to the cornea, nerves controlling the muscles of the eye, the lens, optic nerve and retina. The retina is the complication that most people and medical professionals think of first in terms of diabetic complications.

Diabetic retinopathy is simply damage to the light sensitive retina. This damage is brought about by hyperglycemia, the medical term for high blood sugar. Retinopathy is directly responsible for approximately 12,000 to 24,000 cases of legal blindness every year in the USA alone. It is reported that there are over 200,000 cases each year globally.

Diabetic complications are even more insidious than these numbers because there are several other types of diabetic eye disease created wholly or in part by high blood sugar in diabetics.

What Can Be Done To Prevent Eye Disease?

It stands to reason that the more informed a person is about a particular situation the better equipped they will be to handle it. Diabetic eye disease is just such a case in point. We need to think of the whole person and not just the eyes when discussing diabetic education because diabetic complications run from eye disease, heart disease, nerve damage, kidney damage, etc. Although benfotiamine has been found useful for all of the above, for the sake of this article in terms of prevention, we will discuss diabetic eye disease in terms of diabetic retinopathy.

Diabetic retinopathy is a disease that every diabetic faces the possibility of suffering from somewhere in the course of their disease. The better patients of diabetes are equipped to handle their disease, the lower their risk that they will develop retinopathy. If retinopathy does develop in a patient who is doing all he/she can do to lessen the impact of blood sugar on their bodies, the better chance that they can live productive lives despite the complications and the slower such complications will progress.

What Works Best?

Unfortunately, there are very few options that are showing much promise for the diabetic in terms of diabetic complications. Benfotiamine has been suggested recently to be a strong deterrent against the development of diabetic retinopathy and also shown to slow its progression significantly if it develops. It is showing great promise in the arena of retinopathy, neuropathy and heart/circulatory conditions brought about by excess sugar in the cells.

Benfotiamine, a lipid soluble derivative of water soluble vitamin B1 (thiamine), has been used for the past 12 years in Europe for the treatment of neuropathy, retinopathy as well as heart and circulatory conditions and has shown no adverse effects.

Much of the current research on benfotiamine can be discovered by typing the term benfotiamine into a search engine such as google, AOL, yahoo, etc.

Conclusion

Diabetic complications are a reality that must be an accepted possibility for every diabetic. Diabetic education is highly necessary so that the diabetic community is able to make informed decisions as to their treatment and prevention methodologies. There are few things that show great promise in preventing and/or helping neuropathy, retinopathy, heart and circulatory problems brought about by diabetes. Keeping blood sugar levels close to normal along with adequate exercise in line with the abilities of each individual has shown to help slow the onset of diabetic complications.

Benfotiamine is a nutritional supplement that has shown to be helpful in Europe over the past 12 years in terms of diabetic complications and is now available in the United States, and might be worth the time to investigate further. How about for the diabetic who faces the insidious nature of diabetic complications?

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy. He can be reached at:

Phone: 505.354.0526

web site: http://www.emuhealthproducts.com/benfotiam ine.html

In The News:

table border=0 width= valign=top cellpadding=2 cellspacing=7trtd valign=top class=jfont style=font-size:85%;font-family:arial,sans-serifbrdiv style=padding-top:0.8em;img alt= height=1 width=1/divdiv class=lha href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.sciencedaily.com/releases/2008/10/081007123642.htmcid=1255170645ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNFuoHFPirVUqaxA5sOXzd-O1K6ftAKilling #39;Angry#39; Immune Cells In Fat Could Fight bDiabetes/b/abrfont size=-1font color=#6f6f6fScience Daily (press release)nbsp;-/font nobr2 hours ago/nobr/fontbrfont size=-1It argues strongly that macrophages are causative for the inflammation that leads to bdiabetes/b [in those who are obese].quot; quot; The most interesting thing is b.../b/fontbrfont size=-1a href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.newswise.com/articles/view/545001/cid=1255170645ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNFkhBvOiTMrUu8r7dwgYwCbFOmzPwbDIABETES/b, INSULIN RESISTANCE, OBESITY, MACROPHAGE/a font size=-1 color=#6f6f6fnobrNewswise (press release)/nobr/font/fontbrfont class=p size=-1a class=p href=http://news.google.com/news?sourceid=navclientie=ISO-8859-1rls=GGLG,GGLG:2005-22,GGLG:enncl=1255170645hl=ennobrall 6 news articles/nobr/a/font/div/font/td/tr/table

table border=0 width= valign=top cellpadding=2 cellspacing=7trtd valign=top class=jfont style=font-size:85%;font-family:arial,sans-serifbrdiv style=padding-top:0.8em;img alt= height=1 width=1/divdiv class=lha href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.citizen-times.com/article/200881007021cid=1255124529ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNGGy28Wn6V3qg9yUZDRSXXF6aYmiQPark Ridge offers new service for bdiabetes/b management/abrfont size=-1font color=#6f6f6fAsheville Citizen-Times,nbsp;NCnbsp;-/font nobr6 hours ago/nobr/fontbrfont size=-1The program is available to patients who are homebound and need help managing their bdiabetes/b in Buncombe, Henderson, Polk and Transylvania counties./fontbrfont size=-1a href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.marketwatch.com/news/story/howard-university-hospital-offers-nomoreclipboardcom/story.aspx%3Fguid%3D%257B2CDD0E4A-F7B0-41F1-90DE-79A15554B771%257D%26dist%3Dhpprcid=1255124529ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNE1P1npxjqZ08BXb_Mr5ASW8mClMAHoward University Hospital Offers NoMoreClipboard.com PHR/a font size=-1 color=#6f6f6fnobrMarketWatch/nobr/font/fontbrfont class=p size=-1a class=p href=http://news.google.com/news?sourceid=navclientie=ISO-8859-1rls=GGLG,GGLG:2005-22,GGLG:enncl=1255124529hl=ennobrall 7 news articles/nobr/a/font/div/font/td/tr/table

table border=0 width= valign=top cellpadding=2 cellspacing=7trtd valign=top class=jfont style=font-size:85%;font-family:arial,sans-serifbrdiv style=padding-top:0.8em;img alt= height=1 width=1/divdiv class=lha href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.marketwatch.com/news/story/vivus-announces-weight-loss-effects/story.aspx%3Fguid%3D%257B9A250157-C249-4BE6-91A9-50BECEC2B477%257D%26dist%3Dhpprcid=1254846596ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNFHo8qinqbusSmt8jFpDJo-V6mAdQVIVUS Announces the Weight Loss Effects of Qnexa in Type 2 bDiabetes/b/abrfont size=-1font color=#6f6f6fMarketWatchnbsp;-/font nobrOct 6, 2008/nobr/fontbrfont size=-1VIVUS had previously reported the positive results of this study, OB-202, at the American bDiabetes/b Association Scientific Meeting in June 2008. b.../b/fontbrfont size=-1a href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.streetinsider.com/Corporate%2BNews/VIVUS%2B(VVUS)%2BAnnounces%2Bthe%2BWeight%2BLoss%2BEffects%2Bof%2BQnexa%2Bin%2BType%2B2%2BDiabetes/4045331.htmlcid=1254846596ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNG25ZCs6kNyj58YkhXCJuemQfdmnQVIVUS (VVUS) Announces the Weight Loss Effects of Qnexa in Type 2 b.../b/a font size=-1 color=#6f6f6fnobrStreetInsider.com (subscription)/nobr/font/fontbrfont class=p size=-1a class=p href=http://news.google.com/news?sourceid=navclientie=ISO-8859-1rls=GGLG,GGLG:2005-22,GGLG:enncl=1254846596hl=ennobrall 12 news articles/nobr/a/font/div/font/td/tr/table

table border=0 width= valign=top cellpadding=2 cellspacing=7trtd width=80 align=center valign=topfont style=font-size:85%;font-family:arial,sans-serifa href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.rttnews.com/ArticleView.aspx%3FId%3D733860cid=1255095303ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNE_PBpwnZYwV_o2wWKGvrX9OVx1Vwimg src=http://news.google.com/news?imgefp=tfgfkfaJGtAJimgurl=www.rttnews.com/ArticleImages/USTopStories/2008/October/AGIX-100708.jpg width=70 height=80 alt= border=1brfont size=-2RTT News/font/a/font/tdtd valign=top class=jfont style=font-size:85%;font-family:arial,sans-serifbrdiv style=padding-top:0.8em;img alt= height=1 width=1/divdiv class=lha href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.northfulton.com/Articles-i-2008-09-25-175222.112113_Alpharettas_AtheroGenics_consents_to_bankruptcy.htmlcid=1255095303ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNFmcfBiCavcsL4KRWhgGmGfZ9G_yAAlpharetta#39;s AtheroGenics consents to bankruptcy/abrfont size=-1font color=#6f6f6fNorthFulton.com,nbsp;GAnbsp;-/font nobr1 hour ago/nobr/fontbrfont size=-1After that point, the company focused on findings that the drug candidate showed a marked reduction in the development of new onset bdiabetes/b in patients b.../b/fontbrfont size=-1a href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.marketwatch.com/news/story/atherogenics-files-chapter-11-bankruptcy/story.aspx%3Fguid%3D%257BDFF7FE90-2F15-4B7A-8C70-8AE13A61E2AE%257D%26dist%3Dhpprcid=1255095303ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNFVLxLXaxNXyFWw-IKLO_5MNM2HFgAtheroGenics Files for Chapter 11 Bankruptcy/a font size=-1 color=#6f6f6fnobrMarketWatch/nobr/font/fontbrfont size=-1a href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://money.cnn.com/news/newsfeeds/articles/apwire/886dd96b1bf5e4f9d5b76196b1fce057.htmcid=1255095303ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNFhdZa4WoSS97zFUkcvca-ArkhnUQAtheroGenics files for Chapter 11 bankruptcy/a font size=-1 color=#6f6f6fnobrCNNMoney.com/nobr/font/fontbrfont size=-1a href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.reuters.com/article/mergersNews/idUSBNG15363620081007cid=1255095303ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNHbu2709d1CD9hA7_3lcp4kyJ_UJAUPDATE 1-AtheroGenics files for Chapter 11 bankruptcy/a font size=-1 color=#6f6f6fnobrReuters/nobr/font/fontbrfont size=-1 class=pa href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.rttnews.com/ArticleView.aspx%3FId%3D733860cid=1255095303ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNE_PBpwnZYwV_o2wWKGvrX9OVx1VwnobrRTT News/nobr/anbsp;- a href=http://www.citywebshopper.net/articles/includes/redirect.php?url=http://www.zacks.com/stock/news/15109/AGIX%2BFiles%2Bfor%2BChapter%2B11cid=1255095303ei=y7rrSNrSHqjk6gO0grH-CAusg=AFQjCNHdxM1ZdWIv-Tk879Frah4fxC1P7gnobrZacks.com/nobr/a/fontbr/font class=p size=-1a class=p href=http://news.google.com/news?sourceid=navclientie=ISO-8859-1rls=GGLG,GGLG:2005-22,GGLG:enncl=1255095303hl=ennobrall 34 news articles/nobr/a/font/div/font/td/tr/table

diabetes - Google News